Chi Tu
13Patents
5h-index
11Co-inventors
63Inventor score
Filing activity: Dec 1, 1994 → Aug 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5580972A | Purine nucleoside modifications by palladium catalyzed methods | Performing Operations; Transporting | 64 | Expired |
| US6020483A | Nucleoside modifications by palladium catalyzed methods | Chemistry; Metallurgy | 52 | Expired |
| US6355787B1 | Purine nucleoside modifications by palladium catalyzed methods and compounds produced | Chemistry; Metallurgy | 46 | Expired |
| US5945527A | Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide | Chemistry; Metallurgy | 38 | Expired |
| US5719273A | Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide | Performing Operations; Transporting | 34 | Expired |
| US6512106B2 | Nucleoside modifications by palladium catalyzed methods | Chemistry; Metallurgy | 1 | Expired |
| US10967019B2 | Method for protecting mitochondria in retina cell | Human Necessities | 0 | Active |
| US5783679A | Purine nucleoside modifications by palladium catalyzed methods and oligonucleotides containing same | Performing Operations; Transporting | 0 | Expired |
| US10493105B2 | Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease | Chemistry; Metallurgy | 0 | Active |
| US10342834B2 | Method for improving mitochondria and method for promoting cell division of stem cell | Human Necessities | 0 | Active |
| US6846918B2 | Nucleoside modifications by palladium catalyzed methods | Chemistry; Metallurgy | 0 | Expired |
| US12429406B2 | Agent for cryopreservation and method for cryopreservation of mitochondria using the same | Chemistry; Metallurgy | 0 | Active |
| US10213467B2 | Method for improving mitochondria and method for promoting cell division of stem cell | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.